Literature DB >> 1392296

Cancer risk assessment for the inhalation of 1,3-butadiene using physiologically based pharmacokinetic modeling.

W H Hallenbeck1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1392296     DOI： 10.1007/bf00193342

Source DB:  PubMed          Journal:  Bull Environ Contam Toxicol        ISSN： 0007-4861            Impact factor:   2.151


× No keyword cloud information.
  5 in total

Review 1.  Chronic toxicity results and ongoing studies of 1,3-butadiene by the National Toxicology Program.

Authors:  R L Melnick; J E Huff; J K Haseman; E E McConnell
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

2.  A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans.

Authors:  J C Ramsey; M E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  1984-03-30       Impact factor: 4.219

3.  Inhalation pharmacokinetics based on gas uptake studies. V. Comparative pharmacokinetics of ethylene and 1,3-butadiene in rats.

Authors:  H M Bolt; J G Filser; F Störmer
Journal:  Arch Toxicol       Date:  1984-10       Impact factor: 5.153

Review 4.  Cancer risk assessment of 1,3-butadiene.

Authors:  I L Cote; S P Bayard
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031

Review 5.  The industrial production and use of 1,3-butadiene.

Authors:  N L Morrow
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031
  5 in total
  1 in total

1.  A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation.

Authors:  G Johanson; J G Filser
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.